Cyient
- P/E
- 33.24
Key Fundamentals
MicrocapIT - ServicesInformation TechnologyPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 12.30%
- Debt to Equity
- 0.54
- EPS (TTM)
- ₹33.48
- Book Value
- ₹458.93
- Market Cap
- —
- P/E (TTM)
- 33.24
- P/B
- 2.43
- ROE
- 8.61%
- Dividend Yield
- 1.05%
- EBITDA
- ₹1,088 Cr
- 52W High
- ₹1,277.00
- 52W Low
- ₹750.30
- Volume
- 0
Peer Comparison
Information Technology › IT Enabled Services
| ₹4,133.50 | 33.20 | ₹45,364 Cr | 6.19 | 0.47% | 21.50% | 26.70% | ₹11,565 Cr | ₹1,322 Cr | |
| ₹1,750.40 | 39.33 | ₹29,871 Cr | 10.73 | 0.00% | 31.40% | 31.50% | ₹3,347 Cr | ₹764 Cr | |
| ₹652.45 | 47.55 | ₹26,704 Cr | 6.91 | 1.81% | 16.30% | 20.90% | ₹5,926 Cr | ₹558 Cr | |
| ₹4,062.30 | 88.56 | ₹24,520 Cr | 11.48 | 0.07% | 32.80% | 37.50% | ₹2,702 Cr | ₹260 Cr | |
| ₹1,623.90 | 47.83 | ₹22,921 Cr | 5.07 | 0.00% | 13.80% | 16.80% | ₹2,836 Cr | ₹478 Cr | |
| ₹43.59 | 20.56 | ₹20,233 Cr | 1.99 | 0.35% | 10.60% | 13.40% | ₹7,617 Cr | ₹994 Cr | |
| ₹1,193.60 | 91.82 | ₹14,545 Cr | 10.89 | 0.00% | 24.90% | 30.20% | ₹537 Cr | ₹134 Cr | |
| ₹1,113.00 | 33.24 | ₹11,921 Cr | 2.43 | 1.05% | 8.61% | 12.30% | ₹8,086 Cr | ₹404 Cr | |
| Median 8 companies | ₹1,408.75 | 43.44 | ₹23,720 Cr | 6.55 | 0.21% | 18.90% | 23.80% | ₹4,637 Cr | ₹518 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 64
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 56
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 45
- Weak
- Sales & profit trajectory 9% weight
- Financial Health
- 48
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 88
- Strong
- Trend strength, vol-adjusted 12% weight
- Ownership
- 68
- Strong
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has been maintaining a healthy dividend payout of 45.7%
Weaknesses
3- The company has delivered a poor sales growth of 12.0% over past five years.
- Company has a low return on equity of 12.8% over last 3 years.
- Company might be capitalizing the interest cost
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bullish | 7 | 4 | 8 |
| Oscillators | Bullish | 2 | 4 | 3 |
| Moving Averages | Neutral | 5 | 0 | 5 |
Oscillators
Bullish
Overall
Bullish
Moving Averages
Neutral
Key readings
- RSI (14)
- 45.53
- Neutral
- MACD (12,26,9)
- 11.51
- Bearish
- SMA (50)
- 1,113.04
- Bearish
- SMA (200)
- 966.14
- Bullish
As of
Analyst Rating
11 of 18 analysts rate Buy, 4 Hold, 3 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +8.92% |
|---|---|
| 5Y | +11.96% |
| 3Y | +6.50% |
| 1Y | −1.25% |
| TTM | +10.34% |
Net profit
| 10Y | +3.76% |
|---|---|
| 5Y | +4.93% |
| 3Y | −3.42% |
| 1Y | −28.55% |
| TTM | −34.20% |
Operating cash flow
| 10Y | +10.97% |
|---|---|
| 5Y | −1.67% |
| 3Y | +12.41% |
| 1Y | −0.38% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.01 pp |
|---|---|
| 5Y | −1.55 pp |
| 3Y | −4.30 pp |
| 1Y | −3.09 pp |
| TTM | −1.16 pp |
Revenue by year
| Mar 2017 | ₹3,586 Cr |
|---|---|
| Mar 2018 | ₹3,914 Cr |
| Mar 2019 | ₹4,618 Cr |
| Mar 2020 | ₹4,427 Cr |
| Mar 2021 | ₹4,132 Cr |
| Mar 2022 | ₹4,534 Cr |
| Mar 2023 | ₹6,016 Cr |
| Mar 2024 | ₹7,147 Cr |
| Mar 2025 | ₹7,360 Cr |
| Mar 2026 | ₹7,268 Cr |
Net profit by year
| Mar 2017 | ₹340 Cr |
|---|---|
| Mar 2018 | ₹403 Cr |
| Mar 2019 | ₹477 Cr |
| Mar 2020 | ₹341 Cr |
| Mar 2021 | ₹364 Cr |
| Mar 2022 | ₹522 Cr |
| Mar 2023 | ₹514 Cr |
| Mar 2024 | ₹703 Cr |
| Mar 2025 | ₹648 Cr |
| Mar 2026 | ₹463 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Cyient Ltd trades at ₹1,242.9 as of 2026-10-26 with a market cap of ₹13,019.75 Cr and a P/E (TTM) of 37.12x against an EPS of ₹33.48. The stock sits near its 52-week high of ₹1,277 after recovering from a low of ₹750.3, but faces a sharp TTM profit decline of -27% even as TTM sales growth remains at 10%.
- Near-zero leverage with a debt-to-equity ratio of just 0.08, providing strong balance sheet flexibility and resilience in a rising-rate environment
- Healthy and consistent dividend payout of 45.7% with a current yield of 0.97%, signalling shareholder-friendly capital allocation
- TTM revenue growth of 10% indicates the top line continues to expand despite broader IT sector headwinds
- 10-year compounded sales CAGR of 9% and 5-year CAGR of 12% demonstrate a durable long-term revenue trajectory
- 10-year stock price CAGR of 9% shows the company has created meaningful long-term shareholder value despite recent weakness
- Strong recovery from the 52-week low of ₹750.3 to the current price of ₹1,242.9, a gain of approximately 66%, reflecting renewed market confidence
- 5-year and 10-year ROE averages of 14% and 15% respectively indicate historically sound capital efficiency
- TTM compounded profit growth is -27%, a sharp deterioration that explains the elevated P/E of 37.12x relative to current earnings power
- 3-year compounded profit CAGR of -5% suggests the profit decline is not a one-off but a sustained trend
- Last-year ROE has fallen to 9% (and trailing ROE is 7.51%), well below the 3-year average of 13% and 10-year average of 15%, indicating declining return on capital
- P/E of 37.12x is elevated for a company delivering negative profit growth, implying the stock is priced for a recovery that has yet to materialize in earnings
- 5-year compounded profit CAGR of only 5% lags the 5-year sales CAGR of 12%, pointing to persistent margin compression
- 5-year stock CAGR of 0% and 3-year CAGR of -11% reflect prolonged underperformance and destruction of medium-term shareholder returns
- Potential capitalisation of interest costs raises questions about the true reported profitability and operating margins
- Price-to-book of 2.71x paired with a trailing ROE of just 7.51% means the stock trades at a significant premium to the returns it currently generates on equity
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Cyient delivered a strong Q2FY27 operationally with record order intake (up 20.8% YoY), highest EBIT in 10 quarters, and robust DET/DLM segment performance, driving the stock to a 52-week high of ₹1,245. However, net profit missed estimates by a wide margin (₹121 crore vs ₹154 crore expected) and declined 8% YoY, while management flagged near-term supply constraints on margins. The trend is improving on order momentum, AI/semiconductor positioning, and margin expansion, but execution on profit conversion and navigating supply headwinds will be key to sustaining the rally.
- Net profit misses estimates Oct 23
Q2FY27 net profit of ₹120-121 crore missed analyst estimate of ₹154 crore. Net profit also declined ~8% YoY from ₹143 crore in the year-ago quarter.
- Near-term supply constraints flagged Oct 22
Management noted near-term supply constraints may impact margins and growth, though healthy order book and ASIC pipeline of over $100 million provide longer-term confidence.
- COO resigns after 22 years Oct 6
Chief Operating Officer Prabhakar Atla resigned effective September 28, 2026, after 22 years at Cyient, creating a leadership gap in operations.
- Record Q2 order intake, EBIT surge Oct 22
Highest-ever Q2 order intake grew 20.8% YoY, with technology orders up 39.7% YoY. EBIT rose 21.6% to ₹228.3 crore, the highest in 10 quarters, with margins expanding to 10.21%.
- Stock hits 52-week high at ₹1,245 Oct 22
Shares rallied ~9% to a 52-week high of ₹1,245, up 15% over the month from a year low of ₹750.30 on March 30, 2026. Market cap reached ₹12,823-13,805 crore.
- DET and DLM segments strong Oct 22
DET revenue rose 8.05% QoQ to ₹1,664 crore with 14.2% EBIT margin. DLM achieved record order book with book-to-bill ratio above 1.6x and revenue growth over 26.5% YoY.
- Independent director term ends Oct 18
Vikas Sehgal ceased as Independent Director on October 16, 2026, after completing his second five-year term. He also left the ESG and Stakeholders' committees.
- Q2FY27 earnings call held Oct 22 Oct 10
Cyient hosted its Q2FY27 earnings call on October 22 at 5:00 pm IST with MD Krishna Bodanapu and CEO Sukamal Banerjee. Company reported $658 million revenue in FY26.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,778 | 1,821 | 1,861 | 1,676 | 1,849 | 1,926 | 1,909 | 1,712 | 1,781 | 1,848 | 1,927 | 2,076 | 2,235 |
| Expenses | 1,453 | 1,495 | 1,526 | 1,411 | 1,552 | 1,648 | 1,611 | 1,484 | 1,567 | 1,614 | 1,705 | 1,813 | 1,926 |
| Operating Profit | 326 | 326 | 335 | 265 | 297 | 278 | 298 | 228 | 214 | 235 | 222 | 263 | 309 |
| OPM % | 18% | 18% | 18% | 16% | 16% | 14% | 16% | 13% | 12% | 13% | 12% | 13% | 14% |
| Other Income | 7 | −32 | 23 | 21 | 51 | −17 | 41 | 70 | 71 | −11 | −45 | 7 | 9 |
| Interest | 27 | 29 | 32 | 26 | 28 | 20 | 19 | 16 | 16 | 14 | 14 | 22 | 37 |
| Depreciation | 66 | 66 | 67 | 66 | 66 | 68 | 68 | 68 | 72 | 70 | 68 | 77 | 84 |
| PBT | 240 | 200 | 259 | 195 | 254 | 174 | 252 | 214 | 197 | 139 | 96.7 | 171 | 197 |
| Tax % | 24% | 23% | 24% | 24% | 27% | 26% | 26% | 26% | 27% | 30% | 31% | 36% | 33% |
| Net Profit | 184 | 153 | 197 | 148 | 187 | 128 | 186 | 157 | 143 | 97 | 66 | 109 | 132 |
| EPS (₹) | 16.1 | 13.28 | 17.06 | 12.97 | 16.14 | 11.02 | 15.35 | 13.85 | 11.48 | 8.26 | 4.93 | 9.37 | 10.92 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,736 | 3,094 | 3,586 | 3,914 | 4,618 | 4,427 | 4,132 | 4,534 | 6,016 | 7,147 | 7,360 | 7,268 | 8,086 |
| Expenses | 2,335 | 2,680 | 3,109 | 3,394 | 3,985 | 3,881 | 3,557 | 3,717 | 5,013 | 5,844 | 6,222 | 6,369 | 7,057 |
| Operating Profit | 401 | 414 | 477 | 520 | 633 | 546 | 575 | 818 | 1,003 | 1,303 | 1,138 | 899 | 1,029 |
| OPM % | 15% | 13% | 13% | 13% | 14% | 12% | 14% | 18% | 17% | 18% | 15% | 12% | 13% |
| Other Income | 122 | 112 | 79 | 147 | 131 | 158 | 140 | 112 | 35 | −2 | 97 | 84 | −40 |
| Interest | 6 | 16 | 17 | 20 | 33 | 49 | 43 | 39 | 100 | 116 | 93 | 61 | 88 |
| Depreciation | 71 | 89 | 95 | 105 | 111 | 188 | 194 | 192 | 257 | 267 | 267 | 278 | 299 |
| PBT | 446 | 421 | 444 | 541 | 620 | 468 | 477 | 698 | 681 | 918 | 875 | 644 | 602 |
| Tax % | 25% | 24% | 24% | 26% | 23% | 27% | 24% | 25% | 24% | 23% | 26% | 28% | — |
| Net Profit | 351 | 320 | 340 | 403 | 477 | 341 | 364 | 522 | 514 | 703 | 648 | 463 | 404 |
| EPS (₹) | 31.43 | 28.94 | 30.54 | 36 | 42.33 | 31.14 | 33.06 | 47.35 | 46.52 | 61.57 | 55.45 | 38.51 | 33.48 |
| Div. Payout % | 25% | 24% | 34% | 36% | 35% | 48% | 51% | 51% | 56% | 49% | 47% | 42% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 56 | 56 | 56 | 56 | 55 | 55 | 55 | 55 | 55 | 56 | 56 | 56 | 52 |
| Reserves | 1,788 | 1,774 | 2,061 | 2,288 | 2,509 | 2,506 | 2,902 | 3,061 | 3,411 | 4,203 | 5,254 | 5,626 | 5,046 |
| Borrowings | 147 | 214 | 211 | 283 | 368 | 711 | 577 | 573 | 1,218 | 788 | 513 | 431 | 2,759 |
| Other Liabilities | 582 | 668 | 798 | 773 | 927 | 870 | 940 | 1,072 | 1,815 | 1,883 | 1,798 | 2,137 | 3,727 |
| Total Liabilities | 2,574 | 2,713 | 3,126 | 3,400 | 3,860 | 4,142 | 4,475 | 4,762 | 6,500 | 6,928 | 7,621 | 8,250 | 11,585 |
| Fixed Assets | 789 | 657 | 751 | 798 | 978 | 1,305 | 1,361 | 1,345 | 2,825 | 2,826 | 2,929 | 3,084 | 6,021 |
| CWIP | 10 | 10 | 26 | 52 | 104 | 146 | 88 | 13 | 44 | 57 | 79 | 5 | 12 |
| Investments | 101 | 160 | 196 | 143 | 55 | 41 | 34 | 445 | 518 | 436 | 502 | 457 | 587 |
| Other Assets | 1,674 | 1,886 | 2,153 | 2,409 | 2,723 | 2,650 | 2,992 | 2,959 | 3,113 | 3,609 | 4,112 | 4,704 | 4,965 |
| Total Assets | 2,574 | 2,713 | 3,126 | 3,400 | 3,860 | 4,142 | 4,475 | 4,762 | 6,500 | 6,928 | 7,621 | 8,250 | 11,585 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 362 | 278 | 420 | 296 | 370 | 582 | 856 | 634 | 554 | 726 | 790 | 787 |
| Investing | −448 | −54 | −153 | −57 | −190 | −146 | −104 | −377 | −1,006 | −537 | −134 | 158 |
| Financing | −32 | −111 | −93 | −136 | −232 | −446 | −253 | −544 | −109 | −266 | −58 | −569 |
| Net Cash Flow | −118 | 113 | 174 | 103 | −52 | −10 | 499 | −287 | −562 | −77 | 598 | 376 |
| Free Cash Flow | 281 | 150 | 316 | 149 | 226 | 369 | 761 | 572 | 489 | 648 | 688 | 693 |
| CFO/EBITDA | 119 | 92 | 109 | 89 | 81 | 133 | 171 | 98 | 68 | 77 | 92 | 118 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 71 | 72 | 66 | 64 | 64 | 60 | 71 | 59 | 68 | 64 | 70 | 66 |
| Inventory Days | — | 189 | 124 | 156 | 160 | 211 | 110 | 178 | 228 | 177 | 185 | 303 |
| Days Payable | — | 599 | 522 | 453 | 323 | 347 | 314 | 336 | 374 | 189 | 126 | 249 |
| Cash Conversion Cycle | 71 | −337 | −331 | −233 | −99 | −76 | −133 | −99 | −78 | 52 | 128 | 119 |
| Working Capital Days | 43 | 41 | 27 | 36 | 47 | 35 | 24 | 23 | 17 | 43 | 64 | 68 |
| ROCE % | 25% | 22% | 22% | 23% | 24% | 17% | 15% | 20% | 20% | 22% | 17% | 12% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Cyient insights
73 extracted metrics across FY12–FY27.
Documents
- Q2 FY27 concall · Oct 2026PPT
- Q1 FY27 concall · Aug 2026Transcript PPT Recording
- Concall · Jun 2026Transcript PPT
- Concall · Jun 2026Transcript
- 16 Oct 2025
- 9 Jun 2026
- 22 Sep 2025
- 17 Oct 2024
- 1 Nov 2023
- 4 Aug 2022
- General announcements 28 Oct 2026
- General announcements 23 Oct 2026
Frequently Asked Questions about Cyient
What does Cyient Ltd do?
Where is Cyient Ltd (CYIENT) listed?
Which sector does Cyient Ltd belong to?
What is the PE ratio of Cyient Ltd?
What is the 52-week high and low of Cyient Ltd?
Does Cyient Ltd pay dividends?
What is the Return on Equity (ROE) of Cyient Ltd?
Company Information
Cyient (formerly Infotech Enterprises Limited) is an Indian multinational technology company that is focused on engineering, manufacturing, data analytics, and networks and operations. Infotech Enterprises Ltd. was established in 1991 in Hyderabad.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CYIENT.md for Cyient Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.